The global nuclear medicine equipment market is estimated to reach $2,647 million by 2022 from $2,012 million in 2015, growing at a CAGR of 3.9% from 2016 to 2022.
Increase in prevalence of cancer, heart-related diseases, and neurological disorders has given rise to the importance of early disease diagnosis, which is expected to positively impact the market growth. The nuclear medicine equipment market is driven by the availability of high-quality equipment, rise in adoption of nuclear medicine equipment, and emergence of innovative & advanced equipment. However, high cost of these equipment and their short half-life, high hospital expense, and high cost related to diagnostic imaging services hinder the market growth.
Oncology is anticipated to dominate the global nuclear medicine equipment market throughout the analysis period, owing to the rise in incidence of cancer and increase in awareness about its early diagnosis. Neurology segment has witnessed highest growth rate as these equipment are used to diagnose and assess the treatment response for various neurological disorders such as Alzheimers disease, brain death/injury, vascular dementia, stroke and transient ischemic attack, and others.
- General Electric Company
- Koninklijke Philips N.V.
- Siemens Aktiengesellschaft
- Digirad Corporation
- Mediso Medical Imaging Systems, Ltd.
- Toshiba Corporation
- Bozlu Holding
- Neusoft Corporation
- Compañía Mexicana de Radiología CGR, S.A de C.V.
Key Topics Covered:
Chapter: 1 Introduction
Chapter: 2 Executive Summary
Chapter: 3 Market Overview
Chapter: 4 Global Nuclear Medicine Equipment Market, By Product Type
Chapter: 5 Global Nuclear Medicine Equipment Market, By Application
Chapter: 6 Nuclear Medicine Equipment Market, By End User
Chapter: 7 Global Nuclear Medicine Equipment Market, By Geography
Chapter: 8 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/c7xd45/nuclear_medicine